{"transactions":[{"id":4638094,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-10-08T21:31:36.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year"}],"balance_after":4993,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000085/form4.xml","form_type":"4"}},{"id":4638093,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-10-08T21:31:36.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":226.3349,"value":1129637.4859,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $222.2135 - $227.581. The price reported above reflects the weighted average sale price."}],"balance_after":479803,"source":{"system":"sec-edgar","filing":"0000943819-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000085/form4.xml","form_type":"4"}},{"id":4638092,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-10-08T21:31:36.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":484794,"source":{"system":"sec-edgar","filing":"0000943819-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000085/form4.xml","form_type":"4"}},{"id":4633929,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2026-10-03T00:24:03.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":417.363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":20073.731,"derivative":{"exercise_price":89.85,"underlying":"Common Stock","underlying_shares":417.363},"source":{"system":"sec-edgar","filing":"0001485164-26-000010","document":"form4-10022026_081058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000010/form4-10022026_081058.xml","form_type":"4"}},{"id":4633061,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-10-02T00:19:22.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":13547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 20, 2025. The shares were earned on August 14, 2026, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant."}],"balance_after":479803,"source":{"system":"sec-edgar","filing":"0000943819-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000075/form4.xml","form_type":"4"}},{"id":4614365,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-09-10T10:40:28.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":9984,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000052/form4.xml","form_type":"4"}},{"id":4614364,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-09-10T10:40:28.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":222.4385,"value":1110190.5535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $220.680 - $225.390. The price reported above reflects the weighted average sale price."}],"balance_after":466256,"source":{"system":"sec-edgar","filing":"0000943819-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000052/form4.xml","form_type":"4"}},{"id":4614363,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-09-10T10:40:28.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471247,"source":{"system":"sec-edgar","filing":"0000943819-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485164/000094381926000052/form4.xml","form_type":"4"}},{"id":691345,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-08-11T10:30:20.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":14975,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000043/form4.xml","form_type":"4"}},{"id":691344,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-08-11T10:30:20.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":205.6895,"value":1026596.2945,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $202.410 - $204.160. The price reported above reflects the weighted average sale price."}],"balance_after":466256,"source":{"system":"sec-edgar","filing":"0000943819-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000043/form4.xml","form_type":"4"}},{"id":691343,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-08-11T10:30:20.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471247,"source":{"system":"sec-edgar","filing":"0000943819-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000043/form4.xml","form_type":"4"}},{"id":712169,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-07-09T11:40:12.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":19966,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000038/form4.xml","form_type":"4"}},{"id":712168,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-07-09T11:40:12.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":218.5475,"value":1090770.5725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $216.772 - $219.700. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000038/form4.xml","form_type":"4"}},{"id":712167,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-07-09T11:40:12.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000038/form4.xml","form_type":"4"}},{"id":718875,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2026-07-02T20:21:23.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":432.776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":19606.716,"derivative":{"exercise_price":86.65,"underlying":"Common Stock","underlying_shares":432.776},"source":{"system":"sec-edgar","filing":"0001485164-26-000008","document":"form4-07022026_080717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000008/form4-07022026_080717.xml","form_type":"4"}},{"id":745345,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-06-09T18:26:30.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24957,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000035/form4.xml","form_type":"4"}},{"id":745344,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-06-09T18:26:30.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":193.962,"value":968064.342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $192.605 - $194.715. The price reported above reflects the weighted average sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 32.671 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan."}],"balance_after":466256,"source":{"system":"sec-edgar","filing":"0000943819-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000035/form4.xml","form_type":"4"}},{"id":745343,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-06-09T18:26:30.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000035/form4.xml","form_type":"4"}},{"id":762419,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-27T20:14:37.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":1517.274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":13757,"derivative":{"underlying":"Common Stock","underlying_shares":1517.274},"source":{"system":"sec-edgar","filing":"0001485164-26-000006","document":"form4-05272026_080533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000006/form4-05272026_080533.xml","form_type":"4"}},{"id":762418,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2026-05-27T20:14:37.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":875.35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":19173.94,"derivative":{"exercise_price":85.68,"underlying":"Common Stock","underlying_shares":875.35},"source":{"system":"sec-edgar","filing":"0001485164-26-000006","document":"form4-05272026_080533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000006/form4-05272026_080533.xml","form_type":"4"}},{"id":785537,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-05-11T11:33:48.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":29948,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000030/form4.xml","form_type":"4"}},{"id":785536,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-05-11T11:33:48.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":207.8206,"value":1037232.6146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $206.45 -  $210.47. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000030/form4.xml","form_type":"4"}},{"id":785535,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-05-11T11:33:48.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000030/form4.xml","form_type":"4"}},{"id":811862,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-04-09T15:44:13.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":34939,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000021/form4.xml","form_type":"4"}},{"id":811861,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-04-09T15:44:13.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":225.5032,"value":1125486.4712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $222.5643 - $227.96. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000021/form4.xml","form_type":"4"}},{"id":811860,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-04-09T15:44:13.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000021/form4.xml","form_type":"4"}},{"id":820596,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2026-04-02T20:13:58.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":420.97,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 48.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":18245.033,"derivative":{"exercise_price":89.08,"underlying":"Common Stock","underlying_shares":420.97},"source":{"system":"sec-edgar","filing":"0001485164-26-000004","document":"form4-04022026_080452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000004/form4-04022026_080452.xml","form_type":"4"}},{"id":849489,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-03-11T12:29:35.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":39930,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000016/form4.xml","form_type":"4"}},{"id":849488,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-03-11T12:29:35.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":251.0322,"value":1252901.7102,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from  $246.83 - $253.09. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000016/form4.xml","form_type":"4"}},{"id":849487,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-03-11T12:29:35.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000016/form4.xml","form_type":"4"}},{"id":912849,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-02-10T18:33:22.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":44921,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000011/form4.xml","form_type":"4"}},{"id":912848,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-02-10T18:33:22.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":273.7801,"value":1366436.4791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $270.25 - $276.35. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000011/form4.xml","form_type":"4"}},{"id":912847,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-02-10T18:33:22.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000011/form4.xml","form_type":"4"}},{"id":943615,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2026-01-08T20:23:57.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":49912,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000003/form4.xml","form_type":"4"}},{"id":943614,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-01-08T20:23:57.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":248.4603,"value":1240065.3573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $246.801 - $249.969. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000003/form4.xml","form_type":"4"}},{"id":943613,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2026-01-08T20:23:57.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381926000003/form4.xml","form_type":"4"}},{"id":952659,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2026-01-05T21:04:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":415.144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 41.590 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":17775.682,"derivative":{"exercise_price":90.33,"underlying":"Common Stock","underlying_shares":415.144},"source":{"system":"sec-edgar","filing":"0001485164-26-000002","document":"form4-01052026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516426000002/form4-01052026_090157.xml","form_type":"4"}},{"id":976726,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2025-12-09T20:17:15.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":54903,"derivative":{"exercise_price":146.34,"exercise_date":"2020-11-11","expiration_date":"2026-11-21","underlying":"ResMed Common Stock","underlying_shares":4991},"source":{"system":"sec-edgar","filing":"0000943819-25-000187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000187/form4.xml","form_type":"4"}},{"id":976725,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-12-09T20:17:15.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":4991,"price":251.4117,"value":1254795.7947,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $249.63 - $255.775. The price reported above reflects the weighted average sale price."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-25-000187","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000187/form4.xml","form_type":"4"}},{"id":976724,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-12-09T20:17:15.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":4991,"price":146.34,"value":730382.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":471214,"source":{"system":"sec-edgar","filing":"0000943819-25-000187","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000187/form4.xml","form_type":"4"}},{"id":987902,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed  Common Stock Options","published_at":"2025-11-26T20:29:18.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":33288,"price":250.52,"value":8339309.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026."}],"balance_after":33288,"derivative":{"exercise_price":250.52,"exercise_date":"2026-11-11","expiration_date":"2032-11-11","underlying":"ResMed Common Stock","underlying_shares":33288},"source":{"system":"sec-edgar","filing":"0000943819-25-000183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000183/form4.xml","form_type":"4"}},{"id":990602,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-24T15:42:37.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":7297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on November 16, 2022."}],"balance_after":466223,"source":{"system":"sec-edgar","filing":"0000943819-25-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000170/form4.xml","form_type":"4"}},{"id":990601,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-24T15:42:37.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":13551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met."}],"balance_after":473520,"source":{"system":"sec-edgar","filing":"0000943819-25-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000170/form4.xml","form_type":"4"}},{"id":1000935,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-13T22:37:19.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2205.697,"price":250.1,"value":551644.8197,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2024."}],"balance_after":459969,"source":{"system":"sec-edgar","filing":"0000943819-25-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000116/form4.xml","form_type":"4"}},{"id":1000934,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-13T22:37:19.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3459.325,"price":250.1,"value":865177.1825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023."}],"balance_after":462175,"source":{"system":"sec-edgar","filing":"0000943819-25-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000116/form4.xml","form_type":"4"}},{"id":1000933,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-13T22:37:19.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2231.545,"price":250.1,"value":558109.4045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022."}],"balance_after":465634,"source":{"system":"sec-edgar","filing":"0000943819-25-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000116/form4.xml","form_type":"4"}},{"id":1004236,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock Options","published_at":"2025-11-11T00:07:54.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":false,"shares":7028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":0,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":7028},"source":{"system":"sec-edgar","filing":"0000943819-25-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000095/form4.xml","form_type":"4"}},{"id":1004235,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock Options","published_at":"2025-11-11T00:07:54.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":false,"shares":983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":7028,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":983},"source":{"system":"sec-edgar","filing":"0000943819-25-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000095/form4.xml","form_type":"4"}},{"id":1004234,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-11T00:07:54.000Z","date":"2025-11-07","kind":"sale","planned":true,"acquired":false,"shares":8011,"price":249.7532,"value":2000772.8852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $248.13 - $251.46. The price reported above reflects the weighted average sale price."}],"balance_after":467866,"source":{"system":"sec-edgar","filing":"0000943819-25-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000095/form4.xml","form_type":"4"}},{"id":1004233,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-11T00:07:54.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":true,"shares":7028,"price":101.64,"value":714325.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":475877,"source":{"system":"sec-edgar","filing":"0000943819-25-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000095/form4.xml","form_type":"4"}},{"id":1004232,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":true,"officer_title":"Chairman and CEO"}}],"security":"ResMed Common Stock","published_at":"2025-11-11T00:07:54.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":true,"shares":983,"price":101.64,"value":99912.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 74.3412 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan."}],"balance_after":468849,"source":{"system":"sec-edgar","filing":"0000943819-25-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000095/form4.xml","form_type":"4"}},{"id":1021046,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-10-09T15:03:59.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":8011,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0000943819-25-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000086/form4.xml","form_type":"4"}},{"id":1021045,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-10-09T15:03:59.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":282.8483,"value":2265332.0347,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $280.95 - $283.90. The price reported above reflects the weighted average sale price."}],"balance_after":467792,"source":{"system":"sec-edgar","filing":"0000943819-25-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000086/form4.xml","form_type":"4"}},{"id":1021044,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-10-09T15:03:59.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":475801,"source":{"system":"sec-edgar","filing":"0000943819-25-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000086/form4.xml","form_type":"4"}},{"id":1027823,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2025-10-02T21:16:01.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":382.263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 42.678 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":17318.948,"derivative":{"exercise_price":98.1,"underlying":"Common Stock","underlying_shares":382.263},"source":{"system":"sec-edgar","filing":"0001485164-25-000007","document":"form4-10022025_091057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000148516425000007/form4-10022025_091057.xml","form_type":"4"}},{"id":1045252,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-09-09T20:10:04.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":16020,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0000943819-25-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000061/form4.xml","form_type":"4"}},{"id":1045251,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-09-09T20:10:04.000Z","date":"2025-09-08","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":278.1359,"value":2227590.4231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $275.27 - $279.57. The price reported above reflects the weighted average sale price."}],"balance_after":467792,"source":{"system":"sec-edgar","filing":"0000943819-25-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000061/form4.xml","form_type":"4"}},{"id":1045250,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-09-09T20:10:04.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":475801,"source":{"system":"sec-edgar","filing":"0000943819-25-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000061/form4.xml","form_type":"4"}},{"id":1062903,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-08-19T18:28:50.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":12289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest1/3\neach year on the anniversary of the grant."}],"balance_after":467792,"source":{"system":"sec-edgar","filing":"0000943819-25-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000039/form4.xml","form_type":"4"}},{"id":1070785,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-08-11T14:45:50.000Z","date":"2025-08-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":24029,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0000943819-25-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000038/form4.xml","form_type":"4"}},{"id":1070784,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-08-11T14:45:50.000Z","date":"2025-08-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":279.4829,"value":2238378.5461,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $277.76 - $282.66. The price reported above reflects the weighted average sale price."}],"balance_after":455503,"source":{"system":"sec-edgar","filing":"0000943819-25-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000038/form4.xml","form_type":"4"}},{"id":1070783,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-08-11T14:45:50.000Z","date":"2025-08-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463512,"source":{"system":"sec-edgar","filing":"0000943819-25-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000038/form4.xml","form_type":"4"}},{"id":1090272,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-07-09T12:37:55.000Z","date":"2025-07-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":32038,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0000943819-25-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000027/form4.xml","form_type":"4"}},{"id":1090271,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-07-09T12:37:55.000Z","date":"2025-07-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":256.7207,"value":2056076.0863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $255.6 - $258.22. The price reported above reflects the weighted average sale price."}],"balance_after":455503,"source":{"system":"sec-edgar","filing":"0000943819-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000027/form4.xml","form_type":"4"}},{"id":1090270,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-07-09T12:37:55.000Z","date":"2025-07-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463512,"source":{"system":"sec-edgar","filing":"0000943819-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000027/form4.xml","form_type":"4"}},{"id":1096002,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2025-07-02T20:36:30.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":466.469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":16894.007,"derivative":{"exercise_price":91.11,"underlying":"Common Stock","underlying_shares":466.469},"source":{"system":"sec-edgar","filing":"0001062993-25-012469","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325012469/form4.xml","form_type":"4"}},{"id":1116891,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-06-10T22:35:44.000Z","date":"2025-06-09","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":40047,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0000943819-25-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000019/form4.xml","form_type":"4"}},{"id":1116890,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-06-10T22:35:44.000Z","date":"2025-06-09","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":251.2061,"value":2011909.6549,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $248.57 - $252.31. The price reported above reflects the weighted average sale price."}],"balance_after":455503,"source":{"system":"sec-edgar","filing":"0000943819-25-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000019/form4.xml","form_type":"4"}},{"id":1116889,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-06-10T22:35:44.000Z","date":"2025-06-09","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463512,"source":{"system":"sec-edgar","filing":"0000943819-25-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000094381925000019/form4.xml","form_type":"4"}},{"id":1128084,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T23:21:19.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":1404.798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":12239.726,"derivative":{"underlying":"Common Stock","underlying_shares":1404.798},"source":{"system":"sec-edgar","filing":"0001062993-25-010736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325010736/form4.xml","form_type":"4"}},{"id":1128083,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2025-06-02T23:21:19.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":810.46,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the \"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 36.578 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":16427.538,"derivative":{"exercise_price":92.54,"underlying":"Common Stock","underlying_shares":810.46},"source":{"system":"sec-edgar","filing":"0001062993-25-010736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325010736/form4.xml","form_type":"4"}},{"id":1154376,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-05-09T15:01:20.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":48056,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0001127602-25-013796","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225013796/form4.xml","form_type":"4"}},{"id":1154375,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-05-09T15:01:20.000Z","date":"2025-05-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":243.2268,"value":1948003.4412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $241.50 - $245.09. The price reported above reflects the weighted average sale price."}],"balance_after":455503,"source":{"system":"sec-edgar","filing":"0001127602-25-013796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225013796/form4.xml","form_type":"4"}},{"id":1154374,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-05-09T15:01:20.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30.3711 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan."}],"balance_after":463512,"source":{"system":"sec-edgar","filing":"0001127602-25-013796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225013796/form4.xml","form_type":"4"}},{"id":1174926,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-04-09T14:52:15.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":56065,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0001127602-25-011839","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225011839/form4.xml","form_type":"4"}},{"id":1174925,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-04-09T14:52:15.000Z","date":"2025-04-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":209.8513,"value":1680699.0617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $200.18 - $218.54. The price reported above reflects the weighted average sale price."}],"balance_after":455472,"source":{"system":"sec-edgar","filing":"0001127602-25-011839","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225011839/form4.xml","form_type":"4"}},{"id":1174924,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-04-09T14:52:15.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463482,"source":{"system":"sec-edgar","filing":"0001127602-25-011839","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225011839/form4.xml","form_type":"4"}},{"id":1184238,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2025-04-03T00:40:00.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":288.863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 32.604 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":15580.5,"derivative":{"exercise_price":112.51,"underlying":"Common Stock","underlying_shares":288.863},"source":{"system":"sec-edgar","filing":"0001062993-25-006908","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325006908/form4.xml","form_type":"4"}},{"id":1213315,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-03-11T15:04:52.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":64074,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0001127602-25-008958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225008958/form4.xml","form_type":"4"}},{"id":1213314,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-03-11T15:04:52.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":229.2037,"value":1835692.4333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $223.64 - $232.39. The price reported above reflects the weighted average sale price."}],"balance_after":455472,"source":{"system":"sec-edgar","filing":"0001127602-25-008958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225008958/form4.xml","form_type":"4"}},{"id":1213313,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-03-11T15:04:52.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463481,"source":{"system":"sec-edgar","filing":"0001127602-25-008958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225008958/form4.xml","form_type":"4"}},{"id":1274855,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2025-02-11T17:54:46.000Z","date":"2025-02-07","kind":"exercise","planned":true,"acquired":false,"shares":8009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":72083,"derivative":{"exercise_price":101.64,"exercise_date":"2019-11-11","expiration_date":"2025-11-14","underlying":"ResMed Common Stock","underlying_shares":8009},"source":{"system":"sec-edgar","filing":"0001127602-25-004041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225004041/form4.xml","form_type":"4"}},{"id":1274854,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-02-11T17:54:46.000Z","date":"2025-02-07","kind":"sale","planned":true,"acquired":false,"shares":8009,"price":236.772,"value":1896306.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $235.74 - $238.67 The price reported above reflects the weighted average sale price."}],"balance_after":455472,"source":{"system":"sec-edgar","filing":"0001127602-25-004041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225004041/form4.xml","form_type":"4"}},{"id":1274853,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2025-02-11T17:54:46.000Z","date":"2025-02-07","kind":"exercise","planned":true,"acquired":true,"shares":8009,"price":101.64,"value":814034.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024."}],"balance_after":463481,"source":{"system":"sec-edgar","filing":"0001127602-25-004041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760225004041/form4.xml","form_type":"4"}},{"id":1315848,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2025-01-03T21:08:52.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":307.386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 33.106 phantom stock units accrued on October 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":15259.033,"derivative":{"exercise_price":105.73,"underlying":"Common Stock","underlying_shares":307.386},"source":{"system":"sec-edgar","filing":"0001062993-25-000138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325000138/form4.xml","form_type":"4"}},{"id":1350038,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed  Common Stock Options","published_at":"2024-11-27T20:19:42.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":33036,"price":249.56,"value":8244464.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":33036,"derivative":{"exercise_price":249.56,"exercise_date":"2025-11-11","expiration_date":"2031-11-25","underlying":"ResMed Common Stock","underlying_shares":33036},"source":{"system":"sec-edgar","filing":"0001127602-24-028165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028165/form4.xml","form_type":"4"}},{"id":1350037,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-27T20:19:42.000Z","date":"2024-11-27","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":249.665,"value":499330.0,"ownership":{"direct":false,"nature":"Lisette and Michael Farrell Foundation"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-24-028165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028165/form4.xml","form_type":"4"}},{"id":1350036,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-27T20:19:42.000Z","date":"2024-11-27","kind":"gift","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Lisette and Michael Farrell Foundation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-24-028165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028165/form4.xml","form_type":"4"}},{"id":1350035,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-27T20:19:42.000Z","date":"2024-11-27","kind":"gift","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Lisette and Michael Farrell Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift of shares transferred to The Lisette and Michael Farrell Family Foundation, Mr. Farrell retains dispositive power over remaining shares."}],"balance_after":2090,"source":{"system":"sec-edgar","filing":"0001127602-24-028165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224028165/form4.xml","form_type":"4"}},{"id":1369841,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":14683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents date options first become exercisable. Options vest 1/3 per year."}],"balance_after":0,"derivative":{"exercise_price":84.98,"exercise_date":"2018-11-11","expiration_date":"2024-11-16","underlying":"ResMed Common Stock","underlying_shares":14683},"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1369840,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":3452.9,"price":252.38,"value":871442.902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023."}],"balance_after":455472,"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1369839,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":2226.863,"price":252.38,"value":562015.68394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022."}],"balance_after":458925,"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1369838,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":3101.376,"price":252.38,"value":782725.27488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021."}],"balance_after":461152,"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1369837,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":14683,"price":246.259,"value":3615820.897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $244.74 - $248.38 The price reported above reflects the weighted average sale price."}],"balance_after":464254,"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1369836,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-11-12T22:37:30.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":14683,"price":84.98,"value":1247761.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84.129 shares of ResMed stock purchased on October 31, 2024, through the ResMed Employee Stock Purchase Plan."}],"balance_after":478937,"source":{"system":"sec-edgar","filing":"0001127602-24-027086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/form4.xml","form_type":"4"}},{"id":1388793,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2024-10-09T17:44:44.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":false,"shares":14683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":14683,"derivative":{"exercise_price":84.98,"exercise_date":"2018-11-11","expiration_date":"2024-11-16","underlying":"ResMed Common Stock","underlying_shares":14683},"source":{"system":"sec-edgar","filing":"0001127602-24-025362","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224025362/form4.xml","form_type":"4"}},{"id":1388792,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-10-09T17:44:44.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":14683,"price":231.9149,"value":3405206.4767,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $230.66 - $234.70 The price reported above reflects the weighted average sale price."}],"balance_after":464169,"source":{"system":"sec-edgar","filing":"0001127602-24-025362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224025362/form4.xml","form_type":"4"}},{"id":1388791,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock","published_at":"2024-10-09T17:44:44.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":true,"shares":14683,"price":84.98,"value":1247761.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024."}],"balance_after":478852,"source":{"system":"sec-edgar","filing":"0001127602-24-025362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224025362/form4.xml","form_type":"4"}},{"id":1394967,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2024-10-02T20:22:57.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":301.596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 30.724 phantom stock units accrued on July 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":14918.541,"derivative":{"exercise_price":107.76,"underlying":"Common Stock","underlying_shares":301.596},"source":{"system":"sec-edgar","filing":"0001062993-24-017257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299324017257/form4.xml","form_type":"4"}},{"id":1411381,"issuer":{"id":2692,"kind":"organization","name":"RESMED INC","symbol":"RMD"},"owners":[{"id":24792,"kind":"person","name":"Farrell Michael J.","position":1,"cik":"0001485164","reported_name":"Farrell Michael J.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"ResMed Common Stock Options","published_at":"2024-09-11T01:11:21.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":14683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents date options first became exercisable. Options vest 1/3 per year."}],"balance_after":29366,"derivative":{"exercise_price":84.98,"exercise_date":"2018-11-11","expiration_date":"2024-11-16","underlying":"ResMed Common Stock","underlying_shares":14683},"source":{"system":"sec-edgar","filing":"0001127602-24-023757","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/943819/000112760224023757/form4.xml","form_type":"4"}}],"next_cursor":"2024-09-11T01:11:21.000000Z,1411381"}